Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT02972762
Other study ID # XiangyaH
Secondary ID
Status Enrolling by invitation
Phase Early Phase 1
First received November 16, 2016
Last updated December 13, 2017
Start date November 2016
Est. completion date December 2018

Study information

Verified date November 2016
Source Xiangya Hospital of Central South University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators,according to the eligibility criteria,plane to choose 80 elderly anticipates who will undergo selective hip replacement surgery.This participants will be randomly divided into 2 groups:light anesthesia depth group(L Group) and deep anesthesia depth group (D Group).Before anesthesia induction,each participant will be given lumbar plexus and sciatic nerve block in order to control pain of interoperative and postoperative.During operation period,the L Group will be kept in light anesthesia depth(BIS:50-60),while the D group will be kept in deep anesthesia depth(BIS:35-45)--The BIS values in the range of 30-60 have been recommended in general anesthesia.After operation,a PCIA(patient controlled intravenous analgesia) analgesia pump will be given to each participant to control postoperative pain. The investigator will evaluate the mental state of participant with MMSE(mini-mental state examination) before surgery and review each participant with a CAM-CR for 3 days after surgery to assess the situation of postoperation delirium.intraoperative awareness,postoperative pain will also be investigated in postoperative days 1, 2, 3.


Description:

The investigators,according to the eligibility criteria,plane to choose 80 elderly participants who will undergo selective hip replacement surgery.This participants will be randomly divided into 2 groups:light anesthesia depth group(BIS:50-60) and deep anesthesia depth group (BIS:35-45)--The BIS values in the range of 30-60 have been recommended in general anesthesia.Before anesthesia induction,each participant will be given lumbar plexus and sciatic nerve block in order to control pain of intraoperative and postoperative.The investigator use propofol 4ug\kg、and sufentanil 0.2ug\kg during anesthesia induction period,after that,a Laryngeal mask will be placed into patient's mouth.Anesthesia is maintained with remifentanil TCI(target-controlled infusion) target-controlled infusion(concentration:2ng/ml) and propofol BIS closed-loop target-controlled infusion.During the operation period ,the investigator keep the L Group`s BIS range from 50 to 60.While the D Group`s BIS range from 35 to 45.All participants receive postoperative analgesia.After operation,all participants will be send to PACU(post-anaesthesia care unit ) to wake up and send back to ward,And a PCIA(patient controlled intravenous analgesia) analgesia pump will be given to each participants to control postoperative pain.The investigators will use MMSE(mini-mental state examination) to evaluate the participant's mental state before surgery.For 3 days after operation,The investigator will review each participant with a CAM-CR to assess the situation of postoperation delirium.The investigator will see if there is intraoperative awareness by asking questions.Postoperative pain(with VAS) will also be investigated in postoperative days 1, 2, 3.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 80
Est. completion date December 2018
Est. primary completion date December 2018
Accepts healthy volunteers No
Gender All
Age group 60 Years and older
Eligibility Inclusion Criteria:

1. participant who is selected to undergo hip replacement surgery.

2. participant who is older than 60 years old.

3. participant whose ASA(The American Society of Anesthesiologists) is II-III.

4. participant whose BMI is 18-25.

5. participant who is able to understand and complete The Confusion Assessment Method(CAM-CR).

6. participant who is able to finish Visual Analogue Scale(VAS).

7. participant who is conscious and willing to take part in this research.

8. participant and his/her relatives are willing to take part in this research.

Exclusion Criteria:

1. participant who has serious liver or kidney disease.

2. participant who suffer from mental or neurologic disease,such as Alzheimer disease.

3. participant who has undergone cardiovascular surgery or neurosurgery.

4. participant who has have sedation or antidepression medicine for a long time.

5. participant who has something wrong with his/her vision or hearing.

6. participant who has blood coagulation dysfunction.

7. participant who is an illiteracy.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Diprivan
anesthesia will be maintained with remifentanil and Diprivan.we use Diprivan close-loop to control the anesthesia depth,and the anesthesia depth will be detected with BIS machine.the usage of remifentanil?ropivacaine?sufentanil and cisatracurium in both arms is no difference.

Locations

Country Name City State
China Xiangya hospital of CSU Changsha Hunan

Sponsors (1)

Lead Sponsor Collaborator
Xiangya Hospital of Central South University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary postoperative delirium score(with The Confusion Assessment Method) the The Confusion Assessment Method is widely used to access the postoperative delirium all around the world.the total score more than 22 means that the The participant has got delirium. 3 days
Primary final data analysis the investigators use SPSS software to analysis data. 10 days
Secondary postoperative pain score(with visual analogue scale) 3 days
Secondary intraoperative awareness 1 day
See also
  Status Clinical Trial Phase
Completed NCT02062437 - Clinical and Radiological Results of Total Hip Arthroplasty Using a Ceramic Friction Pair N/A
Completed NCT00393848 - Effectiveness of Two Types of Treatment in Restoring Muscle After Hip or Knee Surgery Phase 2
Completed NCT01496300 - Benefit of Orthopedic Navigation in the ARThroplasty of the Hip Phase 4
Completed NCT00244400 - Examine the Possible Association of Hepatic CYP3A Activity and the Susceptibility to Femur Head Necrosis N/A
Recruiting NCT02230826 - Observational Study to Evaluate Long-Term Outcome in Hip Arthroplasty
Completed NCT02062450 - Observational Study Evaluating Outcomes of Hip Arthroplasty Using Tornier Dual Mobility Acetabular Cup N/A
Not yet recruiting NCT06410079 - Difference in Return to Sports Activity After Hip Arthroplasty by THR or Resurfacing
Active, not recruiting NCT02288117 - Prospective Clinical 5-year Follow-up of the LINK® SP-CL® Hip Prosthesis Stem
Completed NCT02379663 - Prophylaxis of Deep Vein Thrombosis Following Total Hip Arthroplasty Phase 4
Enrolling by invitation NCT02365077 - GWAS Identified Susceptibility Loci for Glucocorticoid-induced FHN in the Chinese Population
Completed NCT02733900 - Modifications of the Subchondral Bone in Aseptic Osteonecrosis of the Femoral Head N/A
Not yet recruiting NCT02633904 - Investigation of the Femoral Shortening Osteotomy in the Developmental Dislocation of the Hip (FSODDH) N/A
Withdrawn NCT02799654 - Excia T Cementless EBRA Study N/A